Back to School: How biopharma can reboot drug development. Access exclusive analysis here

IAVI hunts outside the box

Most HIV vaccines in the pipeline work to reduce viral load and slow progression to AIDS, but they don't completely prevent infection. The International AIDS Vaccine Initiative is launching a new fund to nurture technologies being developed outside the HIV space that could provide greater protection from infection.

IAVI President and CEO Seth Berkley noted there are about 30 AIDS vaccine candidates in clinical testing, most of

Read the full 667 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE